Findlay G P, Spittal M J
Intensive Therapy Unit, University Hospital Wales, Cardiff.
Br J Anaesth. 1996 Apr;76(4):526-9. doi: 10.1093/bja/76.4.526.
We have studied, in 150 patients undergoing elective oral surgery, the effectiveness and sequelae of pretreatment with rocuronium for reducing myalgia after suxamethonium. Patients were allocated randomly to one of three groups: anaesthesia was induced with propofol and fentanyl, and group V received vecuronium 1 mg, group R rocuronium 6 mg and group P placebo pretreatment. Suxamethonium 1.5 mg kg-1 was given 60 s after the pretreatment agent. All patients received ketorolac 10 mg i.v. and morphine 10 mg i.m. for analgesia. The incidence of postoperative myalgia on day 1 after rocuronium (20%) was significantly less than after vecuronium (42%) (P < 0.05) or placebo (70%) (P < 0.01). By day 4 the incidence of myalgia was 28.6% in the rocuronium group, 46.3% in the vecuronium group and 95% in the placebo group. Intubating conditions were not affected adversely by any pretreatment regimen.
我们对150例行择期口腔手术的患者进行了研究,观察罗库溴铵预处理在减轻琥珀胆碱后肌痛方面的有效性及后遗症。患者被随机分为三组:用丙泊酚和芬太尼诱导麻醉,V组接受1 mg维库溴铵,R组接受6 mg罗库溴铵,P组接受安慰剂预处理。预处理药物给药60秒后给予1.5 mg/kg琥珀胆碱。所有患者静脉注射10 mg酮咯酸和肌肉注射10 mg吗啡用于镇痛。罗库溴铵预处理后第1天术后肌痛的发生率(20%)显著低于维库溴铵组(42%)(P<0.05)或安慰剂组(70%)(P<0.01)。到第4天,罗库溴铵组肌痛发生率为28.6%,维库溴铵组为46.3%,安慰剂组为95%。任何预处理方案均未对插管条件产生不利影响。